Clinical trial
Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)
NCT00195897 · Centre Henri Becquerel, Other · Terminated
Key facts
| NCT number | NCT00195897 |
|---|---|
| Title | Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX) |
| Official title | Early Assessment of Anthracycline-induced Cardiotoxicity: Usefulness of Biochemical Markers and Ventricular Function Assessment. |
| Lead sponsor | Centre Henri Becquerel, Other |
| Collaborators | Ligue contre le cancer, France |
| Status | Terminated |
| Study type | Observational |
| Conditions | Lymphoma, Heart Failure, Congestive |
| Enrollment | 6 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 22, 2016 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: